I

Immunic Therapeutics

Clinical-stage biopharma developing oral autoimmune therapies

Associate Director - GMP Quality Assurance

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timeRemote in USA$160k - $210k /yr

About the Job

Requirements

  • A bachelor's degree in chemistry, pharmacy, biology, engineering, or a related scientific discipline.
  • At least 10 years of GMP experience in the pharmaceutical or biotechnology industry, including at least 5 years in Quality Assurance.
  • Demonstrated experience overseeing contract development and manufacturing organizations and contract laboratories, including batch record review, deviation and corrective and preventive action management, and batch disposition.
  • Strong knowledge of United States and European Union GMP requirements, including 21 CFR Parts 210/211 and Part 11, EU GMP Annexes 13 and 16, and ICH Q7, Q9, and Q10.
  • Direct involvement in at least one regulatory GMP inspection, experience writing quality agreements, and experience conducting GMP audits.
  • Ability to work hands-on and independently in a lean, matrixed organization with external partners.
  • Ability to travel up to 25%, including to partner sites in Europe.

Responsibilities

  • Lead GMP quality oversight of contract manufacturers, testing laboratories, packagers, and distributors for drug substance and drug product, serving as the primary QA contact for assigned partners.
  • Review and approve master and executed batch records, deviations, investigations, change controls, and corrective and preventive actions, and perform batch disposition for clinical supply in the United States and European Union, including support for Qualified Person certification.
  • Build the commercial quality framework, including commercial batch release, annual product quality reviews, complaint handling, recall readiness, and stability program oversight.
  • Provide QA oversight of process performance qualification, analytical method validation and transfer, and other launch-critical activities at partner sites.
  • Drive readiness for pre-approval inspections by leading gap assessments, mock inspections, and inspection-day support with internal teams and partners.
  • Author, negotiate, and maintain quality agreements that define GMP responsibilities, and update them as programs move from clinical to commercial supply.
  • Plan and conduct supplier qualification and periodic GMP audits, and drive audit observations to timely closure.
  • Develop and improve risk-based GMP procedures and quality system processes for deviation, CAPA, change control, document control, and training, scaled for an outsourced model.
  • Partner with CMC, Supply Chain, Regulatory Affairs, and Clinical Operations to keep supply on schedule, and provide quality input to the CMC sections of regulatory submissions.
  • Track and report quality metrics and partner performance, and escalate compliance risks to leadership with clear recommendations.

Desired Qualifications

  • Experience supporting a first commercial launch, including process validation, pre-approval inspections, and marketing application CMC content.
  • Experience with small-molecule drug substance and oral solid dosage forms.
  • Experience building quality systems in a small or virtual company, and familiarity with an electronic quality management system such as Veeva.

About the Company

Immunic Therapeutics

Clinical-stage biopharma developing oral autoimmune therapies

Immunic Therapeutics develops oral therapies for chronic inflammatory and autoimmune diseases and is in clinical-stage development. Its lead candidate, vidofludimus calcium (IMU-838), is an oral small molecule that activates the Nurr1 receptor to protect nerve cells and inhibits DHODH to calm overactive immune responses; its pipeline also includes IMU-856, a SIRT6 modulator aimed at restoring intestinal barrier function, with IMU-381 in preclinical GI programs. The company emphasizes oral, small-molecule drugs with dual actions and pursues partnerships or licensing for commercialization rather than relying on near-term product revenue. Its goal is to advance its drug candidates through clinical trials toward commercialization, potentially via collaborations with larger pharma companies.

Company size
51-200
Company stage
IPO
Headquarters
New York City, New York
Founded
2016

Recently Posted Jobs

Explore more opportunities at Immunic Therapeutics

See more jobs